Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook Life Science Investing
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Life Science Investing
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Pharmaceutical Investing
BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals Life Science Investing
PharmaTher's Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus Life Science Investing
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting Medical Device Investing
PTC for Startups Program Helps Companies Design, Produce, and Launch Next-Generation Products Life Science Investing
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026 Life Science Investing
